Domp’s Program in NAION Selected for Landmark FDA Commissioners National Priority Voucher Program
One of just nine voucher recipients chosen and the only one in…
Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program
REDWOOD CITY, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
